These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15840014)

  • 1. Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause?
    Jones CA; Krolewski AS; Rogus J; Xue JL; Collins A; Warram JH
    Kidney Int; 2005 May; 67(5):1684-91. PubMed ID: 15840014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic CKD/ESRD 2010: a progress report?
    Williams ME
    Semin Dial; 2010; 23(2):129-33. PubMed ID: 20210917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of end-stage renal disease among persons with diabetes--United States, 1990-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Nov; 54(43):1097-100. PubMed ID: 16267496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time trends in the epidemiology of renal transplant patients with type 1 diabetes mellitus over the last four decades.
    Cao C; Hellermann JP; Weber M; Ambühl PM
    Nephrol Dial Transplant; 2006 Mar; 21(3):770-5. PubMed ID: 16401627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial.
    Brancati FL; Whelton PK; Randall BL; Neaton JD; Stamler J; Klag MJ
    JAMA; 1997 Dec; 278(23):2069-74. PubMed ID: 9403420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring secular trends in the likelihood of receiving treatment for end-stage renal disease.
    Hsu CY; Go AS; McCulloch CE; Darbinian J; Iribarren C
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):81-8. PubMed ID: 17699391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002.
    Stewart JH; McCredie MR; Williams SM; Jager KJ; Trpeski L; McDonald SP;
    Nephrology (Carlton); 2007 Oct; 12(5):520-7. PubMed ID: 17803478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002.
    ; Stewart JH; McCredie MR; Williams SM
    Nephrol Dial Transplant; 2006 Aug; 21(8):2178-83. PubMed ID: 16595584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of elderly patients with diabetes and end-stage renal disease.
    Goldfarb-Rumyantzev AS; Rout P
    Semin Dial; 2010; 23(2):185-90. PubMed ID: 20374551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of end-stage renal disease attributed to diabetes among persons with diagnosed diabetes --- United States and Puerto Rico, 1996-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Oct; 59(42):1361-6. PubMed ID: 21030940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival trends in ESRD patients compared with the general population in the United States.
    van Walraven C; Manuel DG; Knoll G
    Am J Kidney Dis; 2014 Mar; 63(3):491-9. PubMed ID: 24210591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of treatment for end-stage renal disease attributed to diabetes mellitus--United States, 1980-1989.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1992 Nov; 41(44):834-7. PubMed ID: 1435669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal replacement therapy due to type 1 diabetes; time trends during 1995-2010--a Swedish population based register study.
    Toppe C; Möllsten A; Schön S; Jönsson A; Dahlquist G
    J Diabetes Complications; 2014; 28(2):152-5. PubMed ID: 24332762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause.
    Wakai K; Nakai S; Kikuchi K; Iseki K; Miwa N; Masakane I; Wada A; Shinzato T; Nagura Y; Akiba T
    Nephrol Dial Transplant; 2004 Aug; 19(8):2044-52. PubMed ID: 15173379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACE-inhibitor use and the long-term risk of renal failure in diabetes.
    Suissa S; Hutchinson T; Brophy JM; Kezouh A
    Kidney Int; 2006 Mar; 69(5):913-9. PubMed ID: 16518351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991 2005).
    Villar E; Chang SH; McDonald SP
    Diabetes Care; 2007 Dec; 30(12):3070-6. PubMed ID: 17848610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions.
    Ritz E; Rychlík I; Locatelli F; Halimi S
    Am J Kidney Dis; 1999 Nov; 34(5):795-808. PubMed ID: 10561134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disproportionately high incidence of diabetes-related end-stage renal disease in the Canary Islands. An analysis based on estimated population at risk.
    Lorenzo V; Boronat M; Saavedra P; Rufino M; Maceira B; Novoa FJ; Torres A
    Nephrol Dial Transplant; 2010 Jul; 25(7):2283-8. PubMed ID: 20064954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States.
    Fatica RA; Port FK; Young EW
    Am J Kidney Dis; 2001 Jun; 37(6):1184-90. PubMed ID: 11382687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology of end-stage renal disease in Georgia.
    McClellan W; Brogan D
    J Med Assoc Ga; 1990 Mar; 79(3):153-6. PubMed ID: 2319217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.